Insider Selling: Phreesia (NYSE:PHR) General Counsel Sells $67,152.96 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison Hoffman sold 6,662 shares of the company’s stock in a transaction on Monday, September 21st. The stock was sold at an average price of $10.08, for a total transaction of $67,152.96. Following the completion of the transaction, the general counsel directly owned 266,574 shares in the company, valued at $2,687,065.92. This trade represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Phreesia Stock Up 0.7%

Shares of NYSE:PHR traded up $0.07 during midday trading on Tuesday, hitting $10.11. 476,751 shares of the stock were exchanged, compared to its average volume of 1,449,417. The company has a market capitalization of $627.22 million, a PE ratio of 59.44 and a beta of 0.86. Phreesia, Inc. has a 52-week low of $7.77 and a 52-week high of $25.00. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76. The business’s fifty day simple moving average is $11.15 and its two-hundred day simple moving average is $10.32.

Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The firm had revenue of $129.46 million during the quarter, compared to analyst estimates of $129.06 million. During the same period in the previous year, the company earned $0.01 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, research analysts predict that Phreesia, Inc. will post 0.33 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

PHR has been the topic of several recent research reports. Robert W. Baird raised their price objective on shares of Phreesia from $10.00 to $11.00 and gave the company a “neutral” rating in a research report on Friday, September 4th. Weiss Ratings cut shares of Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, September 4th. Truist Financial increased their target price on shares of Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a research report on Thursday, May 28th. Needham & Company LLC reaffirmed a “buy” rating and issued a $14.00 price target on shares of Phreesia in a research report on Monday, August 31st. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $19.00 price target on shares of Phreesia in a research note on Thursday, September 3rd. Eight equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $14.00.

Institutional Investors Weigh In On Phreesia

Several hedge funds have recently modified their holdings of the business. EverSource Wealth Advisors LLC increased its position in Phreesia by 1,119.8% during the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after acquiring an additional 3,001 shares during the period. New York State Teachers Retirement System bought a new stake in Phreesia in the 1st quarter valued at $44,000. Rockefeller Capital Management L.P. boosted its holdings in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after purchasing an additional 2,149 shares during the period. Allworth Financial LP acquired a new stake in Phreesia in the 2nd quarter worth $58,000. Finally, Essential Partners LLC grew its position in Phreesia by 2,016.6% in the 1st quarter. Essential Partners LLC now owns 9,313 shares of the company’s stock worth $78,000 after purchasing an additional 8,873 shares during the last quarter. 92.10% of the stock is owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc is a healthcare technology company that provides software and services designed to help healthcare organizations manage patient intake and engagement. Its platform digitizes administrative and clinical processes that traditionally rely on paper forms, manual data entry, and separate payment systems.

The company’s offerings include digital patient check-in and registration, insurance and demographic information collection, appointment-related communications, electronic forms and consent management, patient surveys, and payment processing.